These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2872756)

  • 1. [Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction].
    Halawa B; Mazurek W
    Wiad Lek; 1986 Jan; 39(1):25-30. PubMed ID: 2872756
    [No Abstract]   [Full Text] [Related]  

  • 2. [Improved prognosis using beta blockers after myocardial infarct?].
    Weisswange A
    Lebensversicher Med; 1984 Jan; 36(1):14-9. PubMed ID: 6141479
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-adrenergic blockade for survivors of acute myocardial infarction.
    Frishman WH; Furberg CD; Friedewald WT
    N Engl J Med; 1984 Mar; 310(13):830-7. PubMed ID: 6142420
    [No Abstract]   [Full Text] [Related]  

  • 4. beta-Blockers and myocardial infarction.
    Moser M; Gorlin R
    Arch Intern Med; 1982 Sep; 142(9):1618-9. PubMed ID: 6126165
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Heart Lung; 1984 Jul; 13(4):366-71. PubMed ID: 6145686
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
    Frishman WH; Furberg CD; Friedewald WT
    Curr Probl Cardiol; 1984 Jun; 9(3):1-50. PubMed ID: 6146495
    [No Abstract]   [Full Text] [Related]  

  • 7. Secondary prevention with beta-adrenoceptor blockers in post-myocardial infarction patients.
    Staessen J; Bulpitt C; Cattaert A; Fagard R; Vanhees L; Amery A
    Am Heart J; 1982 Dec; 104(6):1395-9. PubMed ID: 6128918
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of adrenergic beta blockaders after myocardial infarction].
    Ribeiro LG
    Arq Bras Cardiol; 1983 Feb; 40(2):73-6. PubMed ID: 6138018
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta-receptor blockers after revascularization in coronary sclerosis].
    Osterziel KJ
    Dtsch Med Wochenschr; 1995 Sep; 120(37):1258-9. PubMed ID: 7671786
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
    Schröder R
    Z Kardiol; 1985; 74 Suppl 6():165-72. PubMed ID: 2869616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers after myocardial infarction.
    Med Lett Drugs Ther; 1982 Apr; 24(608):43-4. PubMed ID: 6123072
    [No Abstract]   [Full Text] [Related]  

  • 12. [Beta receptor blockers and calcium antagonists in coronary disease. Differential therapeutic aspects].
    Delius W
    Dtsch Med Wochenschr; 1983 Jul; 108(30):1154-8. PubMed ID: 6140156
    [No Abstract]   [Full Text] [Related]  

  • 13. Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction.
    Pedersen TR
    N Engl J Med; 1985 Oct; 313(17):1055-8. PubMed ID: 2864634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forum: beta-adrenoreceptor blockade after acute myocardial infarction.
    Aust N Z J Med; 1982 Apr; 12(2):119-24. PubMed ID: 6124228
    [No Abstract]   [Full Text] [Related]  

  • 15. Are all beta-blockers equally effective in reducing mortality after acute myocardial infarction (AMI)?
    Dickerson LM; Carek PJ
    J Fam Pract; 2001 Aug; 50(8):652. PubMed ID: 11509153
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of 3-month treatment with propranolol, oxprenolol, metoprolol and pindolol on plasma lipids and lipoproteins in patients with primary arterial hypertension].
    Sznajderman M; Cybulska I; Niegowska J; Zawadzki Z; Sznajderman M
    Kardiol Pol; 1985; 28(7):489-99. PubMed ID: 2868145
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-adrenergic blocking agents after myocardial infarction: an undocumented need in patients at lowest risk.
    Griggs TR; Wagner GS; Gettes LS
    J Am Coll Cardiol; 1983 Jun; 1(6):1530-3. PubMed ID: 6133891
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of beta blockers for the reduction of mortality after myocardial infarction.
    Hampton JR
    Eur Heart J; 1981 Aug; 2(4):259-68. PubMed ID: 6117465
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-blockers in the secondary prevention of myocardial infarction: a review of clinical trials of 12 months or more duration.
    Decorde P
    Pharmatherapeutica; 1984; 3(8):515-25. PubMed ID: 6142464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of beta-adrenergic blocking agents after myocardial infarction.
    Talbert RL
    Clin Pharm; 1983; 2(1):68-74. PubMed ID: 6136362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.